Importance of fPSA/tPSA ratio for diagnostic of prostate cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F08%3A00007484" target="_blank" >RIV/61989592:15110/08:00007484 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Importance of fPSA/tPSA ratio for diagnostic of prostate cancer
Original language description
Introduction: Prostate cancer is the most common tumor in the male population in Western Europe and USA. In the Czech Republic incidence is 96.87/100 000 inhabitants (NOR 2005). Prostate cancer is third most frequent causation of death for malignant tumor (28.52/1000 inhabitants). The main diagnostic marker for evidence of prostate cancer is prostate-specific antigen (PSA). In the blood portion of PSA is bound with proteins and the rest is free (free PSA). PSA Author email: is organ-specific but not cancer-specific, and serum levels may be elevated in the presence of benign prostatic hypertrophy, prostatitis and other non-malignant conditions. Low specificity of PSA is the reason for developing of new practices. The aim was to find out efficiency of free to total PSA ratio (fPSA/tPSA) pro diagnostic of the prostate cancer. Material and methods: Since 6/2006 to 2/2008 we provided 543 prostate biopsies on Department of Urology, Teaching Hospital Olomouc. We evaluated 418 cases with fre
Czech name
Význam poměru volného PSA k celkovému PSA pro diagnostiku karcinomu prostaty
Czech description
Význam poměru volného PSA k celkovému PSA pro diagnostiku karcinomu prostaty
Classification
Type
A - Audiovisual production
CEP classification
FJ - Surgery including transplantology
OECD FORD branch
—
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2008
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
ISBN
—
Place of publication
—
Publisher/client name
Urologická klinika Olomouc
Version
—
Carrier ID
—